3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thoracic Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sarcoma
1
Prolactinoma
1
Pituitary ACTH Hypersecretion
1
Paraproteinemias
1
Pancreatic Ductal Adenocarcinoma
1
Nervous System Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Leiomyosarcoma
1
Immunoglobulin Light-chain Amyloidosis
1
Head and Neck Neoplasms
1
Gigantism
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Congenital Abnormalities
1
Combined Pituitary Hormone Deficiency
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Central Nervous System Neoplasms
1
Central Nervous System Diseases
1
Carcinosarcoma
1
Interventions
Gemcitabine
2
130-nm albumin-bound paclitaxel
2
paricalcitol
1
mitazalimab
1
ivosidenib
1
Tissue Banks
1
Specimen Handling
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
Oxaliplatin
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Leucovorin
1
Irinotecan
1
Hydroxychloroquine
1
Glucose
1
Genetic Testing
1
Fluorouracil
1
Fecal Microbiota Transplantation
1
Escitalopram
1
Contrast Media
1
Capecitabine
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Ductal Adenocarcinoma
×
Tissue Banks
×
1 year
×
Clear all
NCT06574620
2026-01-16
ACCELERATE
British Columbia Cancer Agency
Phase NA
Recruiting
200 enrolled